PHARMAGATE – international standards for conducting operational activities, speed and mobility in the administration of business processes, flexible infrastructure, wide geography.
The wide profile of our services that helps companies manage each stage of the process – from development to product output to the area of interest in our region, its success on the market as well as life cycle support
The geography of our services provides your products with access to the markets of CIS countries, i.e. a single country, a group of countries, and the region as a whole
The quality management system for the services of our company complies with the requirements of the international standard ISO 9001: 2015, which serves as an additional guarantor of the quality of the company’s work for our customers
Our specialists will work with you to ensure that the objectives agreed in the approved list of services will be implemented and that work will be completed in the required time for you and, most importantly, within a certain budget
From consulting to development and implementation of the project by parts or to its full implementation in a particular area or region as a whole.
Advice on local legislation and regulatory features, the development of regulatory policies with the formation of optimal solutions
Approval of your product for its subsequent commercialization, access to all areas that interest you
Obtaining the approval for medical use, management of modifications, communication with customers
Identification, assessment, understanding and prevention of adverse reactions or any other problems related to the drug
Organization and support of inspection of production sites and authorized for the quality of offices of companies accredited bodies of the region
Standard programs for open trainings and individual development – for corporate clients on the relevant topics
Leave an application for the information you are interested in and we will contact you
On October 12 PHARMAGATE specialists shared their professional experience at the Eurasian Pharmaceutical Summit.
Representatives of the regions, based on the company’s many years of experience, shared their expert opinion on the specifics of the regulatory situation in the countries of Eurasia. And also, based on approaches to the formation of a regulatory strategy for the countries of Central Asia, the Caucasus, Eastern Europe, they analyzed what challenges will influence the development of markets in the near future and how to ensure a competitive advantage.